In T-ALL/T-LBL, reduced expression of the cytotoxic GZMK and PRF1 genes adversely affects killing by cytotoxic T-lymphocytes as well as the immune response (65, 66). The gene discussed is PRF1; the disease is acute lymphoblastic leukemia.